Georgetown University - Lombardi Cancer Center — Washington D.C., District of Columbia

Georgetown University - Lombardi Cancer Center is a clinical research site located in Washington D.C., District of Columbia, United States 20057.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Georgetown University - Lombardi Cancer Center has participated in 1 clinical trials.

Therapeutic areas: AML.

Sponsors: MacroGenics.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Georgetown University - Lombardi Cancer Center?

Georgetown University - Lombardi Cancer Center has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Georgetown University - Lombardi Cancer Center conducted?

Georgetown University - Lombardi Cancer Center has 1 clinical trials on record. Their work covers AML.

Is Georgetown University - Lombardi Cancer Center accredited by Crixeo Health?

Georgetown University - Lombardi Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Georgetown University - Lombardi Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.